Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;19(8):955-958.
doi: 10.1038/gim.2016.206. Epub 2017 Jan 26.

Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma

Andrew S Brohl  1 , Rajesh Patidar  2 , Clesson E Turner  3 , Xinyu Wen  2 , Young K Song  2 , Jun S Wei  2 , Kathleen A Calzone  2 , Javed Khan  2
Affiliations

Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma

Andrew S Brohl et al. Genet Med. 2017 Aug.

Abstract

Purpose: Ewing sarcoma is a small round blue cell tumor that is highly malignant and predominantly affects the adolescent and young adult population. It has long been suspected that a genetic predisposition exists for this cancer, but the germ-line genetic underpinnings of this disease have not been well established.

Methods: We performed germline variant analysis of whole-genome or whole-exome sequencing of samples from 175 patients affected by Ewing sarcoma.

Results: We discovered pathogenic or likely pathogenic germline mutations in 13.1% of our cohort. Pathogenic mutations were highly enriched for genes involved with DNA damage repair and for genes associated with cancer predisposition syndromes.

Conclusion: Our findings reported here have important clinical implications for patients and families affected by Ewing sarcoma. Genetic counseling should be considered for patients and families affected by this disease to take advantage of existing risk management strategies. Our study also highlights the importance of germline sequencing for patients enrolled in precision-medicine protocols.Genet Med advance online publication 26 January 2017.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no conflict of interest.

References

    1. Worch J, Cyrus J, Goldsby R, Matthay KK, Neuhaus J, DuBois SG. Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation. Cancer Epidemiol Biomarkers Prev. 2011;20(3):449–453. - PMC - PubMed
    1. Abbott DRR, Schiffman J, Lessnick S, Cannon-Albright LA. Abstract 2748: A population-based survey of excess cancers observed in Ewing's sarcoma and in their first-, second-, and third-degree relatives. Cancer Research. 2015;75(15 Supplement):2748.
    1. Cope JU, Tsokos M, Miller RW. Ewing sarcoma and sinonasal neuroectodermal tumors as second malignant tumors after retinoblastoma and other neoplasms. Med Pediatr Oncol. 2001;36(2):290–294. - PubMed
    1. Zhang J, Walsh MF, Wu G, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015;373(24):2336–2346. - PMC - PubMed
    1. Chang W, Brohl A, Patidar R, et al. Multi-Dimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A report from the Center for Cancer Research. Clin Cancer Res. 2016 - PMC - PubMed